Generation Bio Co.
GBIO
$0.3901
$0.01584.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 39.23% | 45.83% | 34.23% | -132.26% | -8.58% |
| Total Depreciation and Amortization | -11.25% | -8.74% | -3.95% | -1.35% | -1.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.58% | -28.62% | -18.22% | 1,298.78% | -30.62% |
| Change in Net Operating Assets | -116.10% | -454.34% | -111.01% | -1,448.37% | 76.14% |
| Cash from Operations | 36.81% | 21.49% | -186.81% | -14.52% | -8.59% |
| Capital Expenditure | 91.75% | 85.08% | 99.04% | -154.04% | -571.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,548.72% | 149.10% | -53.61% | 128.08% | 115.05% |
| Cash from Investing | 3,772.10% | 147.80% | -50.48% | 90.15% | 89.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.73% | -- | -27.79% | -- | -33.70% |
| Repurchase of Common Stock | 88.03% | 87.79% | 73.73% | 37.19% | 37.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.01% | 97.71% | 136.36% | -100.35% | -7.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 303.78% | 86.74% | -118.68% | -1,405.97% | 35.10% |